Krystal Biotech Inc (KRYS) earnings · P/E 40, rev $389.1M
These earnings events as JSON? API free 100/dayKrystal Biotech Inc (KRYS) is a biotechnology company listed on NASDAQ.
This KRYS earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported KRYS revenue for 2025-12-31 was $389.1M. Net income was $204.8M. Revenue was up 33.9% from 2024-12-31 to 2025-12-31. KRYS currently screens at market cap $10.17B and trailing P/E 39.7.
When the next KRYS 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 33.9% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full KRYS research stays on the stock page; the tape stays on the quote page.
KRYS earnings FAQ
What are KRYS's latest revenue and net income?
Latest cached Krystal Biotech Inc (KRYS) revenue for Dec 31, 2025 was $389.1M. Net income was $204.8M. Statements: https://lician.com/financials/krys
What is KRYS's latest diluted EPS?
Latest cached Krystal Biotech Inc (KRYS) diluted EPS for Dec 31, 2025 was $6.84.
What period does the latest KRYS earnings print cover?
The latest cached Krystal Biotech Inc (KRYS) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did KRYS revenue change from the prior cached period?
Cached Krystal Biotech Inc (KRYS) revenue was up 33.9% from $290.5M (Dec 31, 2024) to $389.1M (Dec 31, 2025). Statements: https://lician.com/financials/krys
What is KRYS's P/E ratio?
Krystal Biotech Inc (KRYS) trailing P/E is 39.7 on the latest cached fundamentals snapshot.
Where are KRYS earnings listed?
Cached earnings facts for Krystal Biotech Inc (KRYS) are listed at https://lician.com/earnings/krys. Statements: https://lician.com/financials/krys
Not investment advice.